Head of Clinical Development - Neuropsychiatry

Position Summary The individual will lead an innovative and expert Clinical Development team that enables the strategic design, oversight, and execution of clinical research plans with deep disease area expertise, speed, and rigor across a broad Neuropsychiatry portfolio. Key Responsibilities Oversee design and strategic execution of all Neuropsychiatry clinical programs Supervise the strategic development of protocols and analysis of clinical trials from POC through life cycle management and late stage development (with registrational intent) Provide deep disease area expertise and oversight for clinical components of execution and clinical monitoring Interface with key thought leaders and experts in Neuropsychiatry drug development to strengthen disease area expertise within TA and contribute to TA and business development strategy Serve as the organization's senior expert on Neuropsychiatry clinical development and partner strategically with Research and Early Development teams Partner with key matrix stakeholders to advise the Head of Neuropsychiatry Clinical Dev on critical development decisions and portfolio management Represent organization in critical discussions with Health Authorities in the interpretation of clinical data, clinical trial design experiments, and safety and efficacy profiles of compounds Effectively collaborate with global cross-functional matrix team leaders within the organization Interface with clinical development leaders across Europe, Asia, Latin America and US Develop and promote a workplace culture that values diversity of thought, promotes integrity and creates an atmosphere that supports coaching and fosters accountability Qualifications & Experience Significant clinical research and drug development expertise and leadership experience (10+ years) in Neuropsychiatry Degree Requirements: MD (neuro preferred) Successful track record of leading through influence and working across complex, global organizational matrices Deep understanding of early stage through late-stage drug development issues and challenges, as well as extensive experience designing and conducting innovative Phase 2 and Phase 3 clinical trials within related areas of focus Compensation Overview $415,630 - $503,649 The starting compensation range(s) for this role are listed above for a full-time employee (FTE) basis. Additional incentive cash and stock opportunities (based on eligibility) may be available. The starting pay rate takes into account characteristics of the job, such as required skills, where the job is performed, the employee's work schedule, job-related knowledge, and experience. Final, individual compensation will be decided based on demonstrated experience. Benefits Eligible benefits may vary based on the job and location. For more on benefits, please visit Health Coverage: Medical, pharmacy, dental, and vision care Wellbeing Support: Programs such as BMS Well-Being Account, BMS Living Life Better, and Employee Assistance Programs (EAP) Financial Well-being and Protection: 401(k) plan, short- and long-term disability, life insurance, accident insurance, supplemental health insurance, business travel protection, personal liability protection, identity theft benefit, legal support, and survivor support Work‑life benefits include: Paid Time Off US Exempt Employees: flexible time off (unlimited, with manager approval), 11 paid national holidays (not applicable to employees in Phoenix, AZ, Puerto Rico or Rayzebio employees) Phoenix, AZ, Puerto Rico and Rayzebio Exempt, Non‑Exempt, Hourly Employees: 160 hours annual paid vacation for new hires with manager approval, 11 national holidays, and 3 optional holidays All global employees full and part‑time who are actively employed at and paid directly by BMS at the end of the calendar year are eligible to take advantage of the Global Shutdown. Equal Employment Opportunity Statement Bristol Myers Squibb is an equal opportunity employer. Qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, age, disability, protected veteran status, pregnancy, citizenship, marital status, gender expression, genetic information, political affiliation, or any other characteristic protected by law. R1601910 : Head of Clinical Development - Neuropsychiatry Company: Bristol-Myers Squibb Req Number: R1601910 Updated: 2026-05-02 03:25:53.382 UTC Location: Cambridge Crossing-MA #J-18808-Ljbffr Bristol Myers Squibb